BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 202418)

  • 1. Poliomyelitis: epidemiology and prophylaxis. 5. Results of a two- and three-dose vaccination experiment.
    Metselaar D; McDonald K; Gemert W; van Rens MM; Muller AS
    Bull World Health Organ; 1977; 55(6):755-9. PubMed ID: 202418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poliomyelitis: epidemiology and prophylaxis. 4. Serological and virological surveys conducted after a mass vaccination campaign for the control of a threatening poliomyelitis epidemic.
    Metselaar D; McDonald K; Gemert W; Nottay B; Muli JM
    Bull World Health Organ; 1977; 55(6):747-53. PubMed ID: 202417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization against poliomyelitis: risk/benefit/cost in a changing context.
    Salk J
    Dev Biol Stand; 1979; 43():151-7. PubMed ID: 230106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
    Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
    Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessons from Cuba: mass campaign administration of trivalent oral poliovirus vaccine and seroprevalence of poliovirus neutralizing antibodies.
    Mas Lago P; Ramon Bravo J; Andrus JK; Comellas MM; Galindo MA; de Quadros CA; Bell E
    Bull World Health Organ; 1994; 72(2):221-5. PubMed ID: 8205641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poliomyelitis: epidemiology and prophylaxis. 2. Distribution of oral trivalent vaccine by lay volunteers.
    Metselaar D; Dola SK; Gemert W
    Bull World Health Organ; 1973; 48(4):429-33. PubMed ID: 4543548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2001 serological survey in the Czech Republic--poliomyelitis.
    Matyásová I; Rainetová P; Cástková J
    Cent Eur J Public Health; 2003 Dec; 11 Suppl():S31-5. PubMed ID: 15080257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization of neonates with trivalent oral poliomyelitis vaccine (Sabin).
    Dong DX; Hu XM; Liu WJ; Li JS; Jin YC; Tan SG; Chen TQ; Fu JZ; Niu BY; Yu HM
    Bull World Health Organ; 1986; 64(6):853-60. PubMed ID: 3493854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A seroprevalence study of poliovirus antibody against a collection of recombinant and non-recombinant poliovirus vaccine strains in the population of southern Greece.
    Pliaka V; Ruether IG; Kyriakopoulou Z; Kioussi P; Plakokefalos E; Megalou M; Pratti A; Levidiotou-Stefanou S; Markoulatos P
    Clin Microbiol Infect; 2010 Nov; 16(11):1672-5. PubMed ID: 20148919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vaccination against poliomyelitis. Formation of immunity evaluated according to the results of serological surveys].
    Zabicka J
    Przegl Epidemiol; 1981; 35(3):385-9. PubMed ID: 6276928
    [No Abstract]   [Full Text] [Related]  

  • 11. Anomalous observations on IPV and OPV vaccination.
    John TJ
    Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum conversion rate following oral poliomyelitis immunization in Mali, Africa 1982].
    Ehrengut W; AgRhaly A; Koch I; Koumaré B; Simaga SY; Diallo D
    Monatsschr Kinderheilkd; 1984 Jan; 132(1):29-31. PubMed ID: 6321963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early immunization of neonates with trivalent oral poliovirus vaccine.
    Weckx LY; Schmidt BJ; Herrmann AA; Miyasaki CH; Novo NF
    Bull World Health Organ; 1992; 70(1):85-91. PubMed ID: 1314711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eradication of poliomyelitis in Cuba: a historical perspective.
    Más Lago P
    Bull World Health Organ; 1999; 77(8):681-7. PubMed ID: 10516790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine-associated paralytic poliomyelitis and other diseases with acute flaccid paralysis syndrome in Belarus.
    Samoilovich EO; Feldman EV; Yermalovich MA; Protas II; Titov LP
    Cent Eur J Public Health; 2003 Dec; 11(4):213-8. PubMed ID: 14768785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a two-dose administration of live oral poliovirus vaccine for wild and virulent vaccine-derived poliovirus type 1, 2, 3 strains in Japan.
    Iwai M; Takizawa T; Nakayama T; Matsuura K; Yoshida H; Hasegawa S; Obara M; Horimoto E; Kurata T; Horie H
    Scand J Infect Dis; 2008; 40(3):247-53. PubMed ID: 17907043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poliomyelitis vaccination of infants: preimmunization status and seroconversion.
    Choudhury DS; Nossik NN; Bindu ; Vijayan P; Raghavan NG; Paul SS
    Bull World Health Organ; 1973; 48(2):195-8. PubMed ID: 4352611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined live and inactivated poliovirus vaccine to control poliomyelitis in a developing country--five years after.
    Lasch EE; Abed Y; Marcus O; Gerichter CB; Melnick JL
    Dev Biol Stand; 1986; 65():137-43. PubMed ID: 3556771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poliomyelitis surveillance and vaccine efficacy in Bombay, 1982-87.
    Kim-Farley RJ; Dave KH; Sokhey J; Mandke VB
    Bull World Health Organ; 1989; 67(6):663-7. PubMed ID: 2633881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study on immunization of polio vaccine. I. Observation on an improved immunization schedule].
    Su W
    Zhonghua Liu Xing Bing Xue Za Zhi; 1991 Oct; 12(5):281-3. PubMed ID: 1664295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.